hematopoietic system
N |
• normal Ig class switching in germinal center B cells after immunization with hapten-carrier conjugate NP-CGG
• normal rise and fall of hapten-specific IgG levels after immunization with hapten-carrier conjugate NP-CGG
|
• increased frequency in IgM+ plasma cells
|
• increased frequency and number
|
• persistently high number of hapten-specific IgM+ plasma cells in spleen and bone marrow for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
• high total plasma cell numbers in spleen and bone marrow for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
|
• increased frequency and number of plasma cells and germinal center B cells
|
• high total IgM serum levels for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
• persistently high hapten-specific IgM levels for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
|
immune system
• increased frequency in IgM+ plasma cells
|
• increased frequency and number
|
• persistently high number of hapten-specific IgM+ plasma cells in spleen and bone marrow for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
• high total plasma cell numbers in spleen and bone marrow for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
|
• increased frequency and number of plasma cells and germinal center B cells
|
• high total IgM serum levels for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
• persistently high hapten-specific IgM levels for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
monoclonal gammopathy of uncertain significance | DOID:7442 | J:308792 |